Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cyclothiazide (CAS 2259-96-3)

5.0(1)
Write a reviewAsk a question

See product citations (3)

Alternate Names:
6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2-4-benzothiadiazine-7-sulfonamide 1,1-dioxide
Application:
Cyclothiazide is a potent inhibitor of desensitization of AMPA receptors
CAS Number:
2259-96-3
Purity:
≥98%
Molecular Weight:
389.88
Molecular Formula:
C14H16ClN3O4S2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Cyclothiazide potently inhibits the desensitization of AMPA receptors. Cyclothiazide acts as a positive allosteric modulator of AMPA receptors that potently inhibit AMPA receptor desensitization. AMPA is a transmembrane glutamate receptor composed of the subunits GluR-1,2,3,4. Cyclothiazide is an inhibitor of GABA Receptor.


Cyclothiazide (CAS 2259-96-3) References

  1. Cyclothiazide prolongs low [Mg2+]-induced seizure-like events.  |  Lasztóczi, B. and Kardos, J. 2006. J Neurophysiol. 96: 3538-44. PMID: 16914619
  2. Cyclothiazide: a subunit-specific inhibitor of GABAC receptors.  |  Xie, A., et al. 2008. J Physiol. 586: 2743-52. PMID: 18420703
  3. Cyclothiazide induces seizure behavior in freely moving rats.  |  Kong, S., et al. 2010. Brain Res. 1355: 207-13. PMID: 20678492
  4. Cyclothiazide-induced persistent increase in respiratory-related activity in vitro.  |  Babiec, WE., et al. 2012. J Physiol. 590: 4897-915. PMID: 22753547
  5. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.  |  Johansen, TH., et al. 1995. Mol Pharmacol. 48: 946-55. PMID: 7476926
  6. Cyclothiazide potentiates agonist responses at human AMPA/kainate receptors expressed in oocytes.  |  Sharp, RL., et al. 1994. Eur J Pharmacol. 266: R1-2. PMID: 7511109
  7. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.  |  Desai, MA., et al. 1995. J Pharmacol Exp Ther. 272: 38-43. PMID: 7529311
  8. Cyclothiazide modulates AMPA receptor-mediated increases in intracellular free Ca2+ and Mg2+ in cultured neurons from rat brain.  |  Hoyt, KR., et al. 1995. J Neurochem. 64: 2049-56. PMID: 7536804
  9. Desensitization of AMPA receptors upon multiquantal neurotransmitter release.  |  Trussell, LO., et al. 1993. Neuron. 10: 1185-96. PMID: 7686382
  10. Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors.  |  Wong, LA. and Mayer, ML. 1993. Mol Pharmacol. 44: 504-10. PMID: 7690448
  11. Inhibition by cyclothiazide of neuronal nicotinic responses in bovine chromaffin cells.  |  Nooney, JM. and Feltz, A. 1995. Br J Pharmacol. 114: 648-55. PMID: 7735691
  12. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.  |  Partin, KM., et al. 1994. Mol Pharmacol. 46: 129-38. PMID: 8058047
  13. Modulation of AMPA/kainate receptors by cyclothiazide increases cytoplasmic free Ca2+ and 45Ca2+ uptake in brain neurons.  |  Cebers, G. and Liljequist, S. 1995. Eur J Pharmacol. 290: 105-15. PMID: 8575524

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Cyclothiazide, 10 mg

sc-202560
10 mg
$107.00

Cyclothiazide, 50 mg

sc-202560A
50 mg
$227.00